Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers

NCT03508570 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03508570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
September 21, 2018
Completion date
November 11, 2024
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant peritoneal neoplasm, malignant retroperitoneal neoplasm, metastatic cervical carcinoma, metastatic endometrial carcinoma, metastatic fallopian tube carcinoma, metastatic malignant female reproductive system neoplasm, metastatic ovarian carcinoma, metastatic primary peritoneal carcinoma, peritoneal carcinomatosis, platinum-refractory fallopian tube carcinoma, platinum-refractory malignant female reproductive system neoplasm, platinum-refractory ovarian carcinoma, platinum-refractory primary peritoneal carcinoma, platinum-resistant fallopian tube carcinoma, platinum-resistant malignant female reproductive system neoplasm, platinum-resistant ovarian carcinoma, platinum-resistant primary peritoneal carcinoma, recurrent cervical carcinoma, recurrent endometrial carcinoma, recurrent fallopian tube carcinoma, recurrent malignant female reproductive system neoplasm, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8, stage iva fallopian tube cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva primary peritoneal cancer ajcc v8, stage ivb cervical cancer ajcc v8, stage ivb fallopian tube cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb primary peritoneal cancer ajcc v8, stage ivb uterine corpus cancer ajcc v8